AAM
CVS icon

Auxier Asset Management’s CVS Health CVS Stock Holding History

Auxier Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.2M Sell
100,195
-528
-0.5% -$40.7K 1.03% 31
2025
Q4 		$7.99M Sell
100,723
-1,418
-1% -$112K 1.12% 30
2025
Q3 		$7.7M Sell
102,141
-427
-0.4% -$29.3K 1.08% 29
2025
Q2 		$7.08M Sell
102,568
-4
-0% -$262 1.04% 30
2025
Q1 		$6.95M Sell
102,572
-746
-0.7% -$44.6K 1.04% 31
2024
Q4 		$4.64M Sell
103,318
-1,938
-2% -$109K 0.72% 42
2024
Q3 		$6.62M Sell
105,256
-398
-0.4% -$23.2K 0.98% 34
2024
Q2 		$6.24M Sell
105,654
-4,537
-4% -$284K 0.99% 33
2024
Q1 		$8.79M Sell
110,191
-1,489
-1% -$114K 1.34% 23
2023
Q4 		$8.82M Sell
111,680
-2,898
-3% -$206K 1.43% 19
2023
Q3 		$8M Sell
114,578
-4,578
-4% -$324K 1.36% 21
2023
Q2 		$8.24M Sell
119,156
-300
-0.3% -$21.3K 1.37% 20
2023
Q1 		$8.88M Buy
119,456
+9,680
+9% +$812K 1.53% 15
2022
Q4 		$10.2M Buy
109,776
+1,375
+1% +$133K 1.77% 13
2022
Q3 		$10.3M Sell
108,401
-708
-0.6% -$70.1K 1.99% 11
2022
Q2 		$10.1M Sell
109,109
-25
-0% -$2.44K 1.81% 12
2022
Q1 		$11M Sell
109,134
-100
-0.1% -$10.5K 1.75% 13
2021
Q4 		$11.3M Buy
109,234
+375
+0.3% +$34.7K 1.75% 13
2021
Q3 		$9.24M Buy
108,859
+1,093
+1% +$91.6K 1.56% 16
2021
Q2 		$8.99M Sell
107,766
-452
-0.4% -$37K 1.49% 17
2021
Q1 		$8.14M Buy
108,218
+4,770
+5% +$347K 1.4% 19
2020
Q4 		$7.07M Buy
103,448
+8,250
+9% +$537K 1.31% 19
2020
Q3 		$5.56M Buy
95,198
+2,286
+2% +$142K 1.16% 27
2020
Q2 		$6.04M Buy
92,912
+4,560
+5% +$287K 1.33% 21
2020
Q1 		$5.24M Sell
88,352
-680
-0.8% -$45.4K 1.31% 23
2019
Q4 		$6.61M Buy
89,032
+1,325
+2% +$93K 1.23% 23
2019
Q3 		$5.53M Sell
87,707
-30
-0% -$1.78K 1.11% 32
2019
Q2 		$4.78M Buy
87,737
+1,414
+2% +$76.1K 0.95% 37
2019
Q1 		$4.66M Buy
86,323
+2,828
+3% +$175K 0.96% 38
2018
Q4 		$5.47M Buy
83,495
+14,171
+20% +$1.06M 1.22% 25
2018
Q3 		$5.46M Sell
69,324
-175
-0.3% -$12.5K 1.03% 38
2018
Q2 		$4.47M Sell
69,499
-115
-0.2% -$7.58K 0.9% 40
2018
Q1 		$4.33M Buy
69,614
+255
+0.4% +$18.3K 0.87% 42
2017
Q4 		$5.03M Sell
69,359
-240
-0.3% -$17.4K 0.97% 39
2017
Q3 		$5.66M Buy
69,599
+2,150
+3% +$170K 1.15% 32
2017
Q2 		$5.43M Buy
67,449
+400
+0.6% +$31.6K 1.11% 31
2017
Q1 		$5.26M Buy
67,049
+5,000
+8% +$399K 1.1% 33
2016
Q4 		$4.9M Buy
62,049
+9,850
+19% +$797K 1.06% 32
2016
Q3 		$4.64M Sell
52,199
-150
-0.3% -$14.2K 1.04% 36
2016
Q2 		$5.01M Hold
52,349
– – 1.15% 29
2016
Q1 		$5.43M Sell
52,349
-150
-0.3% -$14.6K 1.29% 23
2015
Q4 		$5.13M Hold
52,499
– – 1.16% 32
2015
Q3 		$5.07M Sell
52,499
-43,150
-45% -$4.54M 1.18% 32
2015
Q2 		$10M Sell
95,649
-350
-0.4% -$35.8K 2.09% 11
2015
Q1 		$9.91M Sell
95,999
-1,800
-2% -$182K 2% 11
2014
Q4 		$9.42M Sell
97,799
-325
-0.3% -$28.6K 1.88% 14
2014
Q3 		$7.81M Sell
98,124
-325
-0.3% -$25.6K 1.63% 19
2014
Q2 		$7.42M Sell
98,449
-350
-0.4% -$26.5K 1.52% 21
2014
Q1 		$7.4M Buy
98,799
+327
+0.3% +$23.1K 1.58% 22
2013
Q4 		$7.05M Sell
98,472
-50
-0.1% -$3.21K 1.48% 20
2013
Q3 		$5.59M Hold
98,522
– – 1.29% 28
2013
Q2 		$5.63M Buy
+98,522
New +$5.71M 1.36% 26

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Auxier Asset Management's CVS Position: Q1 2026 in Review

Auxier Asset Management reduced its CVS Health (CVS) stake by 0.52% in Q1 2026, selling an estimated $40.7K and leaving 100,195 shares worth $7.2M. The position accounts for 1.03% of the portfolio, ranked #31.

Auxier Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.3M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Auxier Asset Management held 100,195 shares of CVS Health worth $7.2M as of Q1 2026.
  • Auxier Asset Management sold 528 CVS Health shares in Q1 2026, an estimated $40.7K.
  • CVS Health made up 1.03% of Auxier Asset Management's portfolio in Q1 2026, its #31 holding.
  • Auxier Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Auxier Asset Management's CVS Health position peaked at $11.3M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.